Makwana Solicitors ( has successfully brought a regulatory compliance matter to a close within days of instruction, securing a positive outcome for a small business client under investigation by the ...

Dawn raids in four counties across the West Midlands and the Northwest of England this morning (29 April) dismantle major ...

There are over 52,000 cases of prostate cancer each year in the UK alone ... available in England for eligible patients following marketing authorisation from the MHRA. This follows the initial ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bristol Myers Squibb’s (NYSE: BMY) Opdivo ...

In dawn raids in four counties across the West Midlands and Northwest of England this morning, 12 suspects were arrested in ...

Autolus Therapeutics, a UCL spinout company, has received authorisation from the UK Medicines and Healthcare products ...

Thousands of patients will benefit from a new cancer jab for more than a dozen types of the disease, with the NHS the first in Europe to offer the new injection. The health service is rolling out an ...

Febuxostat does not appear to increase the risk for major adverse cardiovascular events when compared with no urate-lowering ...

Autolus Therapeutics plc announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted conditional ... for eligible patients in England. AUCATZYL is a car T cell ...

The jab is an injectable form of the immunotherapy drug nivolumab, which can be used to treat 15 cancer types, including skin ...

The NHS is set to roll out a a new five-minute ‘super-jab’ that can treat 15 types of cancer and will ‘transform lives’.

The NHS is launching a revolutionary five-minute 'super-jab' capable of treating 15 types of cancer, potentially saving ...